Literature DB >> 6682625

The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers.

J Fishburn, G Turner, A Daniel, R Brookwell.   

Abstract

An epidemiological study was carried out on the group of moderately retarded brothers (IQ, 30-55) identified by Turner and Turner [1974]. Of the original 58 sets of brothers, 54 sets (now 17 to 32 years old) were traced; another four sets (missed in the earlier survey) were added. Forty-five of the 58 pairs were diagnosed as having nonspecific X-linked mental retardation (MR) giving an overall frequency of 5.57 moderately retarded males/10,000 male births. In 12 of the 45 families, affected males had the fragile(X) and macroorchidism; six had macroorchidism alone, giving a frequency of 2.8 moderately retarded males with X-linked MR and macroorchidism +/- the fragile(X) per 10,000 males. Corresponding heterozygote frequencies are 7.34 and 3.65/10,000 females respectively. A new subgrouping of nonspecific X-linked mental retardation is described in six families: X-linked MR, macroorchidism without the fragile(X). Three other X-linked conditions were identified: in one family, the Coffin-Lowry syndrome, in another, Duchenne muscular dystrophy, and in two families X-linked MR and muscle atrophy. Half (56%) of the obligatory carriers of fra(X)-MR in this study were dull to mildly retarded. The mildly retarded heterozygotes had a significantly higher percentage of fra(X) expressing lymphocytes as compared to the intellectually normal heterozygotes. When the three types of nonspecific X-linked MR for which population frequencies were calculated were considered together, half of the obligatory carriers (46%) were dull or mildly retarded, thus confirming that this condition is a significant cause of mild intellectual handicap in females.

Entities:  

Mesh:

Year:  1983        PMID: 6682625     DOI: 10.1002/ajmg.1320140413

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  25 in total

1.  Fragile X syndrome among children with mental retardation.

Authors:  R Elango; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Comparative frequency of fragile-X (FMR1) and creatine transporter (SLC6A8) mutations in X-linked mental retardation.

Authors:  J L Mandel
Journal:  Am J Hum Genet       Date:  2004-10       Impact factor: 11.025

Review 3.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

Review 4.  Non-specific X linked mental retardation.

Authors:  B Kerr; G Turner; J Mulley; A Gedeon; M Partington
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

5.  A family with mental retardation, variable macrocephaly and macro-orchidism, and linkage to Xq12-q21.

Authors:  J P Johnson; R Nelson; C E Schwartz
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

6.  A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology.

Authors:  S Bundey; T P Webb; A Thake; J Todd
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

7.  Prevalence of the fragile X syndrome in four birth cohorts of children of school age.

Authors:  M Kähkönen; T Alitalo; E Airaksinen; R Matilainen; K Launiala; S Autio; J Leisti
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

Review 8.  The fragile X syndrome: the patients and their chromosomes.

Authors:  M A De Arce; A Kearns
Journal:  J Med Genet       Date:  1984-04       Impact factor: 6.318

9.  The frequency of the fragile X chromosome among schoolchildren in Coventry.

Authors:  T P Webb; S Bundey; A Thake; J Todd
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

10.  Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.

Authors:  K B Nielsen; N Tommerup
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.